Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic Using Yeast Beta Glucan…
McMaster’s research team discovers new mechanism of action for PGX-YBG PGX-YBG demonstrates ability to reprogram macrophages on its own PGX-YBG may be a suitable therapeutic solution for patients with fibrotic lung disease and late stage…